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Post-translational allosteric activation of the P2X7 receptor
through glycosaminoglycan chains of CD44 proteoglycans
GEDD Moura1, SV Lucena1, MA Lima1, FD Nascimento1,2, TF Gesteira1,3, HB Nader1, EJ Paredes-Gamero1,4 and ILS Tersariol1,4
Here, we present evidence for the positive allosteric modulation of the P2X7 receptor through glycosaminoglycans (GAGs) in CHO
(cell line derived from the ovary of the Chinese hamster) cells. The marked potentiation of P2X7 activity through GAGs in the
presence of non-saturating agonists concentrations was evident with the endogenous expression of the receptor in CHO cells. The
presence of GAGs on the surface of CHO cells greatly increased the sensitivity to adenosine 5′-triphosphate and changed the main
P2X7 receptor kinetic parameters EC50, Hill coefﬁcient and Emax. GAGs decreased the allosteric inhibition of P2X7 receptor through Mg
2+.
GAGs activated P2X7 receptor-mediated cytoplasmic Ca
2+ inﬂux and pore formation. Consequently, wild-type CHO-K1 cells were
2.5-fold more sensitive to cell death induced through P2X7 agonists than mutant CHO-745 cells defective in GAGs biosynthesis. In
the present study, we provide the ﬁrst evidence that the P2X7 receptor interacts with CD44 on the CHO-K1 cell surface. Thus, these
data demonstrated that GAGs positively modulate the P2X7 receptor, and sCD44 is a part of a regulatory positive feedback loop
linking P2X7 receptor activation for the intracellular response mediated through P2X7 receptor stimulation.
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INTRODUCTION
Classical pharmacology postulates that receptor activation
occurs through drug-receptor interactions.1,2 Advances achieved
during the last years have increased the knowledge concerning
this activation process and introduced new aspects that might
modulate drug-receptor interactions, for example, receptor
states, oligomerization with other proteins and allosteric
mechanisms.3
Extracellular matrix components, such as glycosaminoglycans
(GAGs) and proteoglycans have shown the modulation of receptor
activity.4,5 The action of heparin on the muscarinic receptor M3
occurred through the heparin/extracellular matrix molecules/
integrin complex, which positively modulates the M3 receptor,
inducing relaxation through increased nitric oxide levels.6 In
addition, heparin activates the serotonin receptor and serotonin
signaling pathways.7 Versican, a cell membrane proteoglycan,
promotes the sensitization of mechanosensitive currents in
nociceptive sensory neurons.8 The interaction between toll-like
receptors and biglycan, a leucine-rich repeat proteoglycan, has
also been described on macrophages.9 Heparan sulfate associated
with extracellular matrix components might interact with gluta-
mate receptors, and this interaction could affect the functional
properties of these proteins.10 The type III transforming growth
factor-β (TGF-β) receptor interacts with heparan sulfate proteo-
glycan and other GAG chains.11
The purinergic P2 receptor family comprises G-protein-coupled
receptors (P2Y) and adenosine 5′-triphosphate (ATP)-gated ion
channel receptors (P2X). These receptor families have acquired
increasing relevance as they comprise 15 members, associated
with several biological processes, including muscle contraction,
neurotransmission, exocrine and endocrine secretion, immune
response, platelet aggregation, inﬂammation, pain, proliferation,
differentiation and cell death.12–15
The P2X receptors include seven members (P2X1-7) that
are activated through ATP or the ATP analogs αβ-MeATP
(α,β-methyleneadenosine 5′-triphosphate), βγ-MeATP (β,γ-methy-
leneadenosine 5′-triphosphate) and BzATP (2′(3′)-O-(4-benzoyl-
benzoyl)adenosine 5′-triphosphate) to promote the opening of
ion channels permeable to small cations, such as Na+, K+ and Ca2+,
eliciting intracellular signaling responses.16 Among them, the P2X7
receptor exhibits a different pharmacological feature, prolonged
stimulation at the mM ATP range leading to the formation of a
nonselective pore in the cellular membrane, which increase the
permeability to organic cations of a molecular mass up to 1
kDa.17,18 Several studies have associated the opening of this
nonselective pore with cytoplasmic calcium inﬂux and membrane
depolarization, causing marked physiological impacts that lead to
necrosis and apoptosis.15,19
The binding of agonists to the P2X7 receptor is tightly regulated
through allosteric mechanisms, which act on either the
extracellular or intracellular/transmembrane domains of the
receptor subunits, such as divalent cations, alcohols, metals
and pH.20 Post-translational mechanisms to regulation P2X
receptor activity have also been described, such as phos-
phoinositides,21 phosphorylation22 and integrins.23,24 Although
previous studies have shown that P2X receptors are associated
with the regulation of cellular biosynthesis and secretion of
proteoglycans,7 the inﬂuence of GAGs on the physiology of these
receptor classes has not been fully evaluated.
Herein we investigated the role of GAGs in P2X7 receptor
activation. We observed that the presence of GAGs positively
regulates the activation of the P2X7 receptor; thereby, increasing
Ca2+ entry and P2X7-dependent cell death. This work provided the
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ﬁrst evidence that cell surface GAGs have a relevant functional
impact on P2X7 receptor physiology, emerging as a new cofactor
necessary for full receptor activity and a new regulatory
mechanism for purinergic signaling at the cellular level.
RESULTS
P2 receptor-mediated calcium inﬂux in CHO cells
To verify whether GAGs modulates the response of P2 receptors,
the P2 response to agonists was compared using wild-type CHO-
K1 cells and mutant CHO-745 cells, which are defective in GAGs
chains. Because most of the P2 receptor activation involves
increased Ca2+ signaling, concentration–response curves were
obtained using different P2 agonists. Adenosine, an ATP
degradation product, which actives P1 receptors, was used to
exclude the participation of these receptors (Figure 1a).
As observed in Figure 1, ATP, ADP (adenosine 5′-diphosphate),
UTP (uridine 5′-triphosphate), UDP (uridine 5′-diphosphate) and
BzATP promoted Ca2+ increase in CHO (cell line derived from the
ovary of the Chinese hamster) cells, suggesting that several P2
receptors are expressed in CHO cells. The addition of 2-MeSATP
(2-(methylthio)adenosine 5′-triphosphate), αβ-MeATP and βγ-MeATP
did not increase intracellular Ca2+, suggesting that the receptors
P2X1, P2X2, P2X3, P2X4 and P2X5 are unlikely involved, consistent
with the results of a previous study.25 Comparative evaluation of
the agonists concentration–response curves showed differences in
Emax when the cells where stimulated with ATP, BzATP and
UDP (Figures 1d and e). Typical time courses are shown in
Supplementary Figure SI1.
Characterization of the P2X7 receptor response in CHO cells
To conﬁrm the presence of the P2X7 receptor and compare the
differences in the responses between CHO-K1 and CHO-745 cells,
pharmacological assays were performed using the antagonist ATP
periodate oxidized (oxATP), a selective antagonist of the P2X7
receptor.26 oxATP abolished the effect of BzATP in both CHO-K1
(Figures 2a and c) and CHO-745 cells (Figures 2b and c). In
addition, 4 mM ATP induced the time-dependent uptake of
propidium iodide (PI) in CHO cells after 30min at 37 °C
(Figure 2d). Notably, mutant CHO-745 cells were 2.5-fold less
sensitive to PI accumulation (Figure 2d). This delayed PI
accumulation reﬂects the slow formation of the putative pore
Figure 1. Concentration–response curves for the ability of adenosine, ATP, ADP, BzATP, UDP or UTP to stimulate Ca2+ inﬂux to cytoplasm of the
CHO cells. Cytoplasmic Ca2+ inﬂux, [Ca2+]cyt, measurements were monitored through changes of the Fluo-4 ﬂuorescence intensity in real time
using the Flex Station 3 microplate reader system. CHO-K1 (●-●) and CHO-745 (□-□) cells were seeded onto black 96-well plates (104 cells/
well). Then, the cells were incubated with Fluo-4 for 1 h at 37 °C. The samples were monitored for 200 s, and the amplitude of the basal and
maximum ﬂuorescence value, after agonist stimulus with adenosine (a), ATP (b), ADP (c), BzATP (d), UDP (e) or UTP (f) to obtain the
corresponding concentration–response curves. The data represent the mean± S.E.M. (N= 6).
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form of the P2X7 receptor (Figure 2d), and might suggest that the
initial Ca2+ inﬂux at 50 s (Figures 2a and b) is the precise channel
for the P2X7 receptor. Moreover, BzATP-stimulated Ca
2+ inﬂux is
negatively modulated through a high concentration of divalent
cations Mg2+ (Figure 2e) and Cu2+ (Figure 2f).
Both CHO cells lines did not show differences in the expression
and cellular localization of the P2X7 receptor
Alterations of the P2X7 response to the agonists ATP and BzATP
observed in CHO-K1 and CHO-745 cells likely reﬂect either
differences in P2X7 expression patterns or modulation mechan-
isms. Antibodies against the P2X7 receptor were used to
investigate the cellular expression of this receptor using ﬂow
cytometry and confocal microscopy. The quantiﬁcation of the
P2X7 receptor expression through ﬂow cytometry revealed that
CHO-K1 and CHO-745 cells expressed similar amounts in the
whole cell (permeabilized cells; Figure 3a). The quantiﬁcation of
only the P2X7 receptor external label (without permeabilization)
also showed similar amounts in both cell lines (Figure 3b).
These results suggest that the secretion of the P2X7 receptor was
not altered in CHO-745 cells. To corroborate this hypothesis,
confocal microscopy was performed after labeling the P2X7
receptor, cellular membrane, endoplasmic reticulum and Golgi
(Figure 3c). We did not observe differences in P2X7 receptor
pattern expression and cellular localization between CHO-K1 and
CHO-745 cells (Figure 3c). These results indicate that the
differences of Ca2+cyt concentration curves in response to ATP and
BzATP are not associated with the cellular expression or cellular
localization of the receptor. Altogether, these data strongly
suggest that the presence of GAGs on the surface of CHO cells
modulates P2X7 receptor activity in response to agonists.
The presence of GAGs at the CHO cell surface increases the
efﬁcacy and potency of P2X7 agonists
Concentration–response curves for ATP and the kinetics para-
meters, EC50, Hill coefﬁcient and Emax, were determined in wild-
type CHO-K1 cells and mutant CHO-745 cells defective in GAG
biosynthesis (Figure 1b). Interestingly, all the kinetic parameters of
Figure 2. Characterization of the P2X7 receptor in CHO cells. Cytoplasmic Ca
2+ inﬂux, [Ca2+]cyt, measurements were monitored through
changes in the Fluo-4 ﬂuorescence intensity in real time using the Flex Station 3 microplate reader system. Time course curves of the Fluo-4
ﬂuorescence intensity, referent to transient Ca2+ inﬂux in CHO-K1 (a) and CHO-745 (b) cells after stimulation with 100 μM BzATP, in the absence
(black symbols) or presence of 300 μM oxATP (white symbols). The cytoplasmic Ca2+ increase in the absence (black bars) or presence of oxATP
(white bars) in CHO cells is shown in c. Time course curves of PI accumulation in CHO-K1 (●-●) and CHO-745 (□-□) cells in response to 4mM
ATP (d). Concentration–response curves for the ability of BzATP to stimulate Ca2+ inﬂux in CHO-K1 (circles) and CHO-745 (squares) cells in the
absence (black) or presence of 10mM MgCl2 (white) (e). Concentration–response curves for the ability of Cu
2+ to block Ca2+ inﬂux mediated
through 100 μM BzATP in CHO-K1 (●-●) and CHO-745 (□-□) cells (f). The data represent the mean± S.E.M. (N= 6). *Po0.05.
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the ATP concentration–response curve were affected by the
presence of GAGs on the CHO cell surface: potency (CHO-K1,
EC50 = 3.2 ± 0.3 μM; CHO-745, 8 ± 1 μM), cooperativity (CHO-K1, Hill
coefﬁcient = 0.9 ± 0.1; CHO-745, 2.0 ± 0.3) and maximal response
(CHO-K1, Emax = 258± 10 URF; CHO-745, 97 ± 7 URF). The presence
of GAGs signiﬁcantly increased the sensitivity to low concentra-
tions of ATP and altered the main P2X7 kinetic parameters (EC50,
Hill coefﬁcient and Emax). Thus, the application of ATP to wild-type
CHO-K1 cells increased the effectiveness of the P2X7 receptor and
reduced the Hill coefﬁcient from 2.0 to 0.9. Conversely, ATP when
applied to CHO-745 cells, in the absence of GAG, decreased P2X7
effectiveness and increased the Hill coefﬁcient from 0.9 to 2.0
(Table 1).
Similarly, GAGs also modulate the calcium inﬂux evoked
through BzATP in CHO cells (Figure 1d). The presence of GAGs
enhanced the effectiveness of BzATP at all concentrations tested
Figure 3. ATP-gated P2X7 receptor is expressed on the CHO cells surface. The P2X7 receptor expression was determined through ﬂow
cytometry analysis. CHO cells were labeled with antibody anti-P2X7 conjugated with Alexa Fluor 488, and the data were collected using a
FACSCalibur ﬂow cytometer (Becton–Dickinson) and analyzed using FlowJo software (Tree Star). The boundary between positive and negative
cells labeled for the P2X7 receptor was determined according to the ﬂuorescence distribution of positive cells relative to unlabeled control
samples. (a) The amount of P2X7 receptor expressed in whole CHO cells. (b) P2X7 receptor expressed at the surface of CHO cells.
(c) Immunoﬂuorescence labeling of P2X7 in CHO-K1 and CHO-745 cells. Cells were stained with DAPI (blue) and immunolabelled with anti-
P2X7 (green) and Alexa Fluor 594 conjugated to WGA (red) at left column; ER-Tracker (red) at central column; and with CellLight Golgi
Fluorescent Protein (red) at right column. The histograms and images are representative of the results of three experiments. Scale bars, 20 μm.
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either by increasing the maximal BzATP response (CHO-K1,
Emax = 275± 8 URF; CHO-745, 136 ± 6 URF) or by reducing the Hill
coefﬁcient from 1.8 ± 0.2 to 1.0 ± 0.1, although there were no
changes in the EC50 (CHO-K1, 23 ± 2 μM; CHO-745, 21 ± 3 μM).
Therefore, the application of BzATP to CHO-K1 cells increases P2X7
effectiveness, whereas for CHO-745 cells, the application of BzATP
decreases P2X7 effectiveness and increases the Hill coefﬁcient
from 1.0 to 1.8 (Table 1).
As expected, Mg2+ changed the BzATP binding to the P2X7
receptor in an allosteric manner in CHO-K1 cells, where the BzATP
maximal response was decreased (CHO-K1 control, Emax = 275± 8
URF; 10 mM Mg2+, Emax = 153 ± 6 URF), the Hill coefﬁcient was
increased (CHO-K1 control, 1.0 ± 0.1; 10 mM Mg2+, 1.5 ± 0,1) and
the BzATP afﬁnity for the receptor was strongly decreased (CHO-
K1 control, 23 ± 2 μM; 10 mM Mg2+, 168 ± 22 μM). Interestingly, the
application of 10mM Mg2+ to CHO-745 cells did not change the
P2X7 receptor maximal response (CHO-745 control, Emax = 136± 6
URF; 10 mM Mg2+, Emax = 119± 10 URF), but Mg
2+ decreased P2X7
effectiveness (CHO-745 control, EC50 = 21 ± 3 μM; 10mM Mg
2+,
EC50 = 150± 11 μM) and increased the Hill coefﬁcient from
1.8 ± 0.2 to 2.8 ± 0.3. The presence of GAGs decreases the
inhibitory effect of Mg2+ by increasing the maximal BzATP
response and reducing the Hill coefﬁcient, although no change
in the EC50 values in the presence of Mg
2+ was observed (Table 1).
P2X7-mediated cell death is upregulated by GAGs
The effect of ATP and BzATP on cell death was evaluated in both
CHO cell lines; therefore, we compared the viability of CHO-K1 and
CHO-745 cells after stimulation with high concentrations of P2X7
agonists for 24 h. The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide) assay showed that a high concentration
of ATP (41mM) and BzATP (4500 μM) promoted cell death in
both lines. However, differences in the percentage of cell death
between CHO-K1 and CHO-745 cells were observed (Figure 4a).
Similar differences in viability were also observed through ﬂow
cytometry using annexin V and 7-amino-actinomycin D (7-AAD;
Figure 4b and c). These data showed that P2X7-mediated CHO cell
death primarily occurs through the apoptosis pathway. Notably,
wild-type CHO-K1 cells were 2.5-fold more sensitive to cell death
induced through P2X7 agonists than the mutant CHO-745 cells
defective in GAG biosynthesis. Moreover, ATP and BzATP
increased morphological changes and cell detachment in CHO
cultures (Figure 4d). Similar results were observed after 48 h of
treatment with P2X7 agonists (Supplementary Figure SI2). These
results reveal GAGs as positive regulators of P2X7 receptor pore
formation, eventually leading to cell death.
Modiﬁcations in GAG chains affect the response of P2X7 receptor
The present data suggest that the rate and extent of P2X7 GAG-
induced sensitization determines the outcome of receptor
activation. To corroborate this assumption, different approaches
were used to examine the role of GAG chains upon P2X7 receptor
function.
We used heparin, which raises the negative charge in the
surrounding, mimicking endogenous GAGs chains on the
receptor.27,28 We examined the effects of depleting or loading
GAGs on P2X7 stimulation through the application of agonists. To
examine the effects of heparin on the P2X7 response, the cells
were pre-incubated with 10, 20, 40 or 100 μM of heparin for 5 min
before P2X7 agonist stimulation. Pre-treatment with heparin
caused a larger increase in the amplitude of Ca2+ inﬂux primarily
evoked in lower concentrations of agonists (Figures 5a–d); for
wild-type CHO-K1 cells, the increase was 120% Ca2+cyt response at
10 μM ATP and 78% at 1 mM ATP (Figure 5a). Similar results were
obtained when the BzATP agonist was used. Notably, 100 μM of
heparin potentiated the Ca2+ inﬂux induced through 3 μM BzATP
2.2-fold (Figure 5c). However, the rate of sensitization through
heparin was reduced in CHO-745 cells; for this group, the increase
was only 40% of Ca2+ response at 10 μM ATP and 50% at 1 mM ATP
(Figure 5b). Similar rates of sensitization were obtained when
CHO-745 cells were also stimulated with BzATP (Figure 5d). In the
absence of ATP or BzATP, even the highest heparin concentration
did not elicit P2X7 stimulation, and at saturation the agonist
concentration (BzATP4100 μM or ATP44mM) of heparin induced
no further increase in Ca2+ inﬂux. These results showed that
heparin markedly sensitized Ca2+ entry through P2X7 at lower
agonist concentrations (ATP and BzATP). These data suggest an
allosteric sensitization mechanism of the receptor through
heparin.
To deplete the GAG function in CHO cells, we treated these cells
with 20 or 50 mM sodium chlorate for 24 h. We used chlorate to
inhibit 3ʹ-phosphoadenosine-5ʹ-phosphosulfate synthase, which
leads to the overall reduction in GAG sulfation.29,30 The pre-
treatment of the wild-type CHO-K1 cells with chlorate inhibited
~ 35% of the total P2X7 agonist (ATP or BzATP) response. As
expected, chlorate did not block the P2X7 agonist response in
defective mutant CHO-745 cells (Figures 5e and f).
In addition, to selectively block GAGs biosynthesis, we treated
CHO cells with o-nitrophenyl-β-D-xylopyranoside. Xylosides act as
exogenous acceptors for the elongation of GAGs chains and
thereby affect endogenous proteoglycans biosynthesis.30,31 The
pre-treatment of CHO-K1 cells with 2 mM xylosides inhibited 55%
of the response induced through 10 μM ATP-gated P2X7 and 82%
of the response induced through 3 μM BzATP-gated P2X7 receptor.
Moreover, as expected, xyloside did not block the P2X7 agonist
response in mutant CHO-745 cells defective in GAG biosynthesis
(Figures 5g and h). Altogether, these results showed that the
perturbation of the GAG/proteoglycans biosynthesis greatly
affects the P2X7 agonist response, revealing GAG/proteoglycans
as an important physiological positive regulator of the native P2X7
receptor.
Molecular association of P2X7 receptor and CD44 proteoglycans
The CHO-K1 lineage expressed syndecan 1, syndecan 2, glypican 6
and CD44. The CHO-745 cells did not express syndecan 1, but
expressed low levels of glypican 6 and CD44, and high levels of
syndecan 2 (Figure 6a–d). In addition, both CHO cell lines did not
express syndecan 3, syndecan 4, glypican 3, glypican 4 and
glypican 5.
Table 1. Kinetic parameters of P2X7 receptor in CHO cells
Agonist CHO-K1 CHO-745
Emax (URF) EC50 (μM) Hill coefﬁcient Emax (URF) EC50 (μM) Hill coefﬁcient
ATP 258± 10 3.2± 0.3 0.9± 0.1 97± 7 8± 1 2.0± 0.3
BzATP 275± 8 23± 2 1.0± 0.1 136± 6 21± 3 1.8± 0.2
BzATP+Mg2+ 153± 6 168± 22 1.5± 0.1 119± 10 150± 11 2.8± 0.3
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To evaluate the molecular association of P2X7 and CD44,
confocal microscopy was performed. As expected, labeling
revealed the co-localization of CD44 expression with the
P2X7 receptor on the CHO-K1 cell surface (Figure 6d). This
interaction was not observed in CHO-745 cells (Figure 6d).
Furthermore, we used immunoprecipitation, followed by immuno-
blotting, to provide direct biochemical evidence for a physical
association between the CD44 proteoglycan and the P2X7
receptor. Both, the P2X7 receptor and CD44, were individually
identiﬁed in the complex molecular mass of 85 and 60 kDa,
respectively (Figure 6e). The 60-kDa form of CD44 coimmuno-
precipitated with the P2X7 receptor, corresponding with the
soluble CD44 ectodomain (sCD44), a proteolytic product released
from the membrane form of CD44 through shedding.32
Figure 4. P2X7-mediated cell death is dependent of GAGs/Proteoglycans in CHO cells. (a) CHO-K1 and CHO-745 cells were incubated with ATP
(1 and 4mM) or BzATP (0.5 and 1mM) for 24 h, at 37 ºC, and the viability of the CHO cell lines was determined using the MTT assay. (b, c) P2X7-
mediated cell death in CHO-K1 and CHO-745 cells was also investigated using annexin V-APC/7-AAD double staining and analyzed through
ﬂow cytometry. The data represent the mean± S.E.M. (N= 6), *Po0.05. (d) CHO cells were stimulated with 4 mM ATP or 1mM BzATP for 24 h.
ATP stimulation induces morphological changes and decreases the CHO cell number as observed in phase contrast microscopy.
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Heparin increases the dynamics of the P2X7 head domain
Here we proposed that the P2X7 channel dynamics are altered
upon heparin binding. To examine this hypothesis, we investi-
gated the relationship between the inherent dynamics of the head
and tail after P2X7 apo, ATP-bound, heparin-bound and ATP–
heparin complexes with the P2X7 receptor using docking,
molecular dynamics and normal mode analysis (NMA).
Figures 7a–f shows the channel volume after 50 ns calculation
Figure 5. The enhancement in P2X7-mediated cytoplasmic Ca
2+ inﬂux is dependent on GAGs/proteoglycans in CHO cells. Concentration–
effect curves for the ability of heparin (0–100 μM) to modulate Ca2+ inﬂux stimulated through ATP at concentrations of 10 μM and 1mM (a and b) or
BzATP at concentrations of 3, 10 and 100 μM (c and d) in CHO-K1 (a and c) and CHO-745 (b and d) cells. CHO-K1 and CHO-745 cells were pre-
incubated with sodium chlorate, an inhibitor of PAPS, at concentrations of 20 and 50mM for 48 h (e and f), or with 2mM o-nitrophenyl-β-D-
xylopyranoside, an inhibitor of endogenous proteoglycan biosynthesis, for 120 h (g and h); the CHO cells were subsequently stimulated with
ATP (e and g) or BzATP (f and h). Cytoplasmic Ca2+ inﬂux measurements in CHO cells were monitored through changes in the Fluo-4
ﬂuorescence intensity in real time using the Flex Station 3 microplate reader system. The data represent the mean± S.E.M. (N= 6). *Po0.05.
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for the apo, P2X7-ATP and P2X7-ATP-heparin complexes as
calculated through HOLLOW 1.2.33 Figures 7g–i shows the RMSD
(root mean square deviation) ﬂuctuations for each of the
monomers of the P2X7 receptor during the 50-ns dynamics
simulations. In the presence of ATP and ATP+heparin, an increase
of ~ 0.2 and 0.4 Å, respectively, was observed in comparison with
the apo structure, likely reﬂecting the increased relative motions
after binding. To evaluate the inﬂuence of heparin binding in
speciﬁc ﬂuctuations of the P2X7 domains, we performed NMA.
These simulations conﬁrmed a more notable conformational
ﬂuctuation of the left ﬂipper and tail domains in the heparin–ATP
complex. These data strongly suggest that the processes to trigger
pore dilation or the formation or recruitment of a pore are
positively inﬂuenced through heparin, suggesting that heparin/
GAGs, in the presence of ATP, promote the long opening-gating
mode of the P2X7 receptor (Supplementary Figures SI3 and SI4).
Figure 6. P2X7 and CD44 colocalize and closely interact in wild-type CHO-K1 cells. (a) Syndecan 1, (b) syndecan 2, (c) glypican 6 and (d) CD44
mRNA constitutive expression in CHO-K1 (black columns) and CHO-745 (white columns) cells, normalized over hypoxanthine–guanine
phosphoribosyltransferase mRNA levels, and expressed as fold increases over controls (CTR, n=4). The data are represented as the means± S.E.M.
(N= 6). *Po0.05. (e) Immunoﬂuorescence labeling with anti-P2X7 (green, ﬁrst column) and anti-CD44 (red, second column) of CHO-K1 and
CHO-745 cells. The nuclei were stained with DAPI (blue). Merge, third column. Scale bars, 20 μm. (f) P2X7 immunoprecipitation of whole-CHO-
K1 cell lysate. Aliquots (500 μg) of cell lysates were incubated with polyclonal anti-P2X7 antibody overnight at 4 °C, followed by the addition of
20 μl of protein A/G PLUS-Agarose for 4 h at 4 °C. The proteins were resolved through 10% SDS-PAGE and transferred onto polyvinylidene
ﬂuoride membranes. The immunoprecipitated proteins were detected using anti-P2X7 and anti-CD44 antibodies, followed by incubation with
the respective secondary antibodies conjugated to horseradish peroxidase. The bands were revealed using the SuperSignal West Pico
Chemiluminescent Substrate.
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DISCUSSION
Here we present evidence for a positive allosteric modulation of
P2X7 through GAGs in CHO cells. These data strongly suggest that
GAGs from the cell surface bind to the P2X7 receptor and thereby
facilitates the binding of ATP to the ligand-gated cation channel.
The presence of GAGs on the CHO cell surface greatly increases
sensitivity to low concentrations of ATP and changes the main
P2X7 kinetic parameters EC50, Hill coefﬁcient and Emax. In the
absence of ATP, even the highest heparin concentrations tested
did not elicit discernible P2X7 activation. The allosteric inhibition
of the P2X7 receptor current through extracellular Mg
2+ was
mitigated in the presence of GAGs. These data suggest the
allosteric sensitization of the receptor through GAGs. In addition,
the formation, recruitment and dilation of the P2X7 pore
augmented in the presence of GAGs as demonstrated through
the acceleration of cellular uptake of the large molecule PI
(MW 668) and molecular dynamic simulations. Increases in Emax of
[Ca2+]cyt and acceleration of PI inﬂux conﬁrmed the potentiating
effect of GAGs on native P2X7 receptors. Consequently, wild-type
CHO-K1 cells were 2.5-fold more sensitive to cell death induced
through P2X7 agonists compared with mutant CHO-745 cells
defective in GAG biosynthesis.
The ability of P2X7 to respond to a large range of ATP
concentrations reﬂects ATP binding to the three sites on the
trimeric receptor with negative cooperativity.34 Where partial ATP
occupancy results in the opening of an intrinsic nonselective pore
for small mono- and divalent cations, including Ca2+, full
occupancy at high ATP concentrations triggers the dilation of
the pore. Thus, the rate and extent of P2X7 sensitization
determines the outcome of receptor activation. In the present
study, we identiﬁed cell surface GAGs as key regulators of P2X7
receptor sensitization and pore dilation. These data support a
model that GAG binding might overcome the conformational
hindrances under conditions of partial agonist occupancy and
thereby promote the long opening-gating mode.
Recently, the modulation of the P2X7 receptor through
hyaluronic acid has also been observed in wound healing35 and
Figure 7. P2X7 molecular dynamics is altered through heparin binding. (a) P2X7 apo trimer, (b) P2X7 bound to ATP and (c) P2X7 bound to ATP
and heparin (pink sticks). The overall shape of the P2X7 pore calculated as hollow under all conditions is shown in red. (d–f) Top view from
a–c, respectively. (g–i) Ca RMSD for each individual subunit during the 50-ns dynamics simulations. Each ribbon color represents one chain
from the representation above, ATP (yellow sticks) and heparin (pink sticks). The images were generated using VMD.
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ophthalmic cells.36 Moreover, soluble biglycan proteoglycan,
released through proteolysis from the extracellular matrix, acts
as a fundamental danger signal through interactions with Toll-like
and purinergic P2X4/P2X7 receptors on the cell surface of
macrophages.9 Together, these data showed that GAG chains
from proteoglycans are new physiologically relevant binding
partners from the cell surface microenvironment that activate the
P2X7 receptor through an allosteric upregulatory mechanism.
Consistent with these data, we demonstrated that P2X7 receptors
interact with CD44 heparan sulfate proteoglycan on the wild-type
CHO-K1 cell surface but not in the CHO-745 line.
CD44 proteoglycan is the major receptor of the extracellular
matrix component hyaluronan,37 which acts as a co-receptor for
growth factors and organizes the actin cytoskeleton through cell
signaling. CD44 is involved in a wide spectrum of physiological
functions, such as cell–cell and cell–matrix interactions, morpho-
genesis, cell migration, cellular differentiation and tumorigenic
process.38 CD44 proteoglycan39 and P2X7 receptor
40 are located in
lipid raft regions at cell membrane. Low cholesterol level in lipid
raft triggers membrane-dependent CD44 shedding41 and induces
P2X7 receptor activation,
42 suggesting that these biological
processes might be associated. Moreover, extracellular ATP
induces CD44 shedding from the cell surface via the activation
of the P2X7 receptor, showing a functional relationship between
CD44 and P2X7 receptors in macrophage-like P388D1 cells.
43
Tumorigenic cells overexpressing P2X7 receptor show an
increased tendency to metastasize,44,45 and paralleling CD44
expression is essential for the anchorage-independent growth
and tumor-initiating ability of highly tumorigenic mammary
epithelial.46 Notably, CD44 proteolytic cleavage serves as a
tumorigenic process by enhancing the proliferation/migration of
cells.47 The extracellular sCD44 proteolytically released domain
affects the function of the membrane form of CD44, acting
as an inhibitor of CD44-dependent cell–cell and cell–matrix
interactions.48,49
Interestingly, ATP-mediated cytoplasmic Ca2+ inﬂux through
P2X7 receptors induces calpain activation.
50–53 Activated calpain
cleaves merlin, a Ezrin/Radixin/Moesin (ERM)-like protein.54
Recently, Hartmann47 showed that merlin activation through
dephosphorylation prevents the proteolytic cleavage of CD44. In
addition, P2X7 receptor stimulation also triggers α-secretase-
dependent proteolytic shedding55 through phosphorylation of
ERM proteins.56 Altogether, these data suggest that P2X7 receptor
stimulation promotes CD44 shedding either through the direct
activation of calpain or through the indirect phosphorylation of
ERM proteins. Notably, calpain activation results in merlin
cleavage, paralleling ERM phosphorylation, which promotes the
activation of α-secretase protease, and both processes result in
CD44 shedding.
Here, we provided the ﬁrst evidence that the P2X7 receptor is
positively modulated through GAG and interacts with CD44 on the
CHO-K1 cell surface. Moreover, we also showed that the P2X7
receptor coimmunoprecipitates with the sCD44 ectodomain,
sCD44, in CHO-K1 lysates. We did not observe this interaction
on the surface of CHO-745 cells, indicating that GAG chains
mediate the interaction of sCD44 proteoglycans with the P2X7
receptor. Therefore, the present study proposes sCD44 as a new
physiologically positive allosteric modulator of the P2X7 receptor;
sCD44 is part of a regulatory positive feedback loop linking P2X7
receptor activation and thereby facilitating the intracellular
response mediated through ATP cell signaling.
MATERIALS AND METHODS
Materials
Nutrient mixture F12 medium, fetal bovine serum (FBS), penicillin,
streptomycin and trypsin, the agonists ATP, ADP, BzATP, UDP, UTP,
2-MeSATP, αβ-MeATP and βγ-MeATP, the antagonist oxATP and other
chemicals, such as dimethyl sulfoxide (DMSO) and MTT, were purchased
from Sigma-Aldrich (St. Louis, MO, USA). Annexin V-APC (An) and 7-AAD
were obtained from BD Biosciences (San Jose, CA, USA). Fluo-4 NW Calcium
Assay kit was obtained from Molecular Probes (Eugene, OR, USA). Protein
A/G PLUS-Agarose and anti-P2X7 receptor and anti-CD44 antibodies were
purchased from Santa Cruz Biotechnology (Dallas, TX, USA). IgG-
conjugated antibodies with horseradish peroxidase were obtained from
Cell Signaling Technology (Danvers, MA, USA). SuperSignal West Pico
Chemiluminescent Substrate and micro BCA were purchased from Thermo
Scientiﬁc (Waltham, MA, USA). TRIzol reagent, 4ʹ,6-diamidino-2-phenylin-
dole (DAPI), secondary antibodies conjugated with Alexa Fluor and
ﬂuorescents organelles markers, such as ER-tracker red, CellLight Golgi
red and Alexa Fluor 594-conjugated wheat germ agglutinin (WGA), were
obtained from Invitrogen (Waltham, MA, USA). The ImProm-II Reverse
Transcriptase System kit was purchased from Promega (Madison, WI, USA),
SYBR Green PCR Master Mix was obtained from Applied Biosystems
(Carlsbad, CA, USA) and the primers were obtained from Integrated DNA
Technologies (Coralville, IA, USA).
Cell lines and culture conditions
This research was conducted using established cell lines. Wild-type CHO-K1
cells and mutant CHO-745 cells, deﬁcient in xylosyltransferase, resulting in
deﬁcient proteoglycan biosynthesis, were kindly donated from Professor
Dr Jeffrey D Esko (Glycobiology Research and Training Center, University of
California, San Diego La Jolla, CA, USA). The CHO cells were cultured in F12
medium containing 10% (v/v) heat-inactivated FBS, 10 U/ml penicillin and
10 μg/ml streptomycin at 37 °C in an atmosphere of 5% (v/v) CO2.
Measurement of cytoplasmic Ca2+
For cytoplasmic Ca2+ concentration measurements, CHO cells were seeded
onto black 96-well plates (104 cells/well) and maintained for 48 h at 37 °C
under an atmosphere of 5% (v/v) CO2. Subsequently, the cells were
incubated with Fluo-4 Direct Calcium Assay reagent for 1 h at 37 °C,
according to the manufacturer’s instructions. The samples were stimulated
with different agonists, and the ﬂuorescence was quantiﬁed using a Flex
Station 3 microplate reader (Molecular Devices, Sunnyvale, CA, USA). The
Fluo-4 was excited at 490 nm and the emission was detected at 525 nm.57
Flow cytometry analysis
P2X7 receptor expression was determined using ﬂow cytometry analysis.
CHO cells were seeded onto six-well plates and maintained for 48 h at
37 °C under an atmosphere of 5% (v/v) CO2. Subsequently, the cells were
harvested using 10mM EDTA in phosphate-buffered saline (PBS) and
adjusted to a concentration of 106 cells per tube. Initially, to examine the
protein expression at the cell surface, the cells were incubated with goat
anti-P2X7 primary antibodies, washed with PBS buffer and labeled with the
respective secondary antibody conjugated to Alexa Fluor 488. In addition,
to label the P2X7 receptor on whole cells, before the procedure mentioned
above, the cells were ﬁxed in 2% paraformaldehyde/PBS for 30min,
washed three times with 0.1 M glycine/PBS and permeabilized with 0.01%
saponin/PBS for 15min. The data were collected using a FACSCalibur ﬂow
cytometer (Becton–Dickinson, Franklin Lakes, NJ, USA) and CellQuest
software (Becton–Dickinson), followed by analysis using FlowJo software
(Tree Star, CA, USA). A total of 10 000 events were collected for each
sample. The boundary between the cells positive and negative for P2X7
receptor labeling was determined according to the ﬂuorescence distribu-
tion of the positive cells relative to the control (unlabeled samples).
Cell viability assay
The viability of CHO cell lines was determined using the MTT assay.58
Brieﬂy, the cells were seeded onto 96-well plates (104 cells/well) and
maintained for 48 h at 37 °C under an atmosphere of 5% (v/v) CO2.
Subsequently, the medium was removed and the cells were incubated
with ATP (1 or 4 mM) or BzATP (0.5 or 1 mM) at a ﬁnal volume of 200 μl/well
in fresh medium for 24 and 48 h. The medium was removed, 100 μl of MTT
(1mg/ml) was added to each well and the cells were incubated again at
37 °C for 4 h. The supernatant was removed and 200 μl/well of DMSO was
added to solubilize the formazan crystals formed. The absorbance was
read at 570 nm using a microplate reader, and the cell viability was
determined using the standard reduction of the MTT. The results were
expressed relative to control cell viability (100%).
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Cell death assay
Cell death was investigated using annexin V-APC/7-AAD double staining
and was analyzed through ﬂow cytometry.57,59 The cells were seeded onto
six-well plates (106 cells/well) and maintained for 48 h at 37 °C under an
atmosphere of 5% (v/v) CO2. Subsequently, the medium was removed, and
the cells were incubated with ATP (1 or 4 mM) or BzATP (0.5 or 1 mM) for 24
and 48 h, followed by harvesting with trypsin, washing with PBS and
resuspending in binding buffer (0.01 M HEPES, pH 7.4, 140 mM NaCl and
2.5 mM CaCl2). The suspensions were transferred to tubes, centrifuged
and resuspended with annexin V-APC and 7-AAD according to the
manufacturer’s instructions. The cells were incubated at room temperature
for 30min, and the viable, apoptotic or necrotic cell populations were
evaluated through ﬂow cytometry. The data were collected using a
FACSCalibur ﬂow cytometer (Becton–Dickinson) and CellQuest software
(Becton–Dickinson), followed by analysis using FlowJo software (Tree Star).
A total of 10 000 events were collected for each sample. The results were
calculated as the percentage of cell death compared with the control.
Dye uptake assay
P2X7 pore formation was functionality examined in CHO cells by analyzing
PI uptake using a FACSCalibur ﬂow cytometer (Becton–Dickinson). The cells
were seeded onto six-well plates (106 cells/well) and maintained for 48 h at
37 °C under an atmosphere of 5% (v/v) CO2. Subsequently, the cells were
harvested using 10mM EDTA/PBS and adjusted to a concentration of
106 cells per tube. The samples were incubated with 5 μM of PI at a ﬁnal
volume of 200 μl/well in fresh serum-free medium F12 for 15min, followed
by the addition of 4 mM ATP and incubation at 37 °C for 30, 60 and 120min,
respectively. The intensity of dye uptake was immediately determined.
A total of 10 000 events were collected for each sample.60,61
Quantiﬁcation of gene expression
Total RNAs were extracted using TRIzol reagent, and the reverse-
transcribed cDNA was obtained using the ImProm-II Reverse Transcriptase
System kit according to the manufacturer's protocol. Real-time quantitative
PCR assays were performed using the SYBR Green PCR Master Mix, and the
primers are described in Supplementary Table SI1. The cycling parameters
for the PCRs were 50 °C for 2 min, 95 °C for 10min, followed by 40 cycles of
95 °C for 15 s and 60 °C for 1 min in an ABI PRISM 7500 Real Time PCR
System (Applied Biosystems). Standard curves were obtained for each
primer pair to assess the efﬁciency of ampliﬁcation. The target mRNA
expression was normalized to the housekeeping gene enzyme hypox-
anthine–guanine phosphoribosyltransferase, and the relative quantiﬁca-
tion of the expression levels (experimental/control) was determined based
on the 2-[Δ]Ct method.62
Confocal immunoﬂuorescence assay
For analysis of expression pattern and cellular localization of the P2X7
receptor through confocal microscopy, CHO cells were seeded (104 cells)
onto coverslips until reaching ~ 60% conﬂuence. Initially, to examine
protein expression at the cell surface, the cells were washed three times
with PBS, incubated with goat anti-P2X7 primary antibody and subse-
quently developed using the respective secondary antibody conjugated to
Alexa Fluor 488. Thereafter, the cells were washed three times with PBS,
and labeled with rat anti-CD44 primary antibody, followed by incubation
with the respective secondary antibody conjugated to Alexa Fluor 594 or
the cell membrane-speciﬁc marker, WGA, conjugated to Alexa Fluor 594.
The cells were ﬁxed with 2% paraformaldehyde/PBS for 30min, washed
three times with 0.1 M glycine/PBS, permeabilized with 0.01% saponin/PBS
for 15min and stained with DAPI for 15min. The coverslips were mounted
onto microscopy slides using Fluoromont G (Immunkemi, Stockholm,
Sweden). In addition, to analyze the P2X7 receptor localization in
intracellular compartments, the CHO cells were labeled with ER-Tracker
red, a endoplasmic reticulum-speciﬁc marker, or transfected with CellLight
Golgi red ﬂuorescent protein, which is exclusively expressed in the Golgi,
according to the manufacturer’s instructions. Subsequently, the cells were
washed, ﬁxed, permeabilized and labeled with the anti-P2X7 receptor
antibody, as described above. Light microscopy analysis was performed
using a confocal laser-scanning Zeiss LSM 780 microscope (Zeiss,
Oberkochen, Germany). The pinhole device was adjusted to capture the
ﬂuorescence of one airy unit. The images were processed using ImageJ
software (National Institutes of Health, Bethesda, MD, USA).
Immunoprecipitation assay and western blot analysis
The cells were lysed with the non-denaturing lysis buffer containing 20mM
Tris, pH 7.4, 2 mM EDTA, 137mM NaCl, 1% Nonidet-P40 and protease/
phosphatase inhibitor cocktail. Aliquots (500 μg) of the lysates were
incubated with polyclonal anti-P2X7 antibody overnight at 4 °C, followed
by the addition of 20 μl of Protein A/G PLUS-Agarose reagent for 4 h at
4 °C. Immune complexes were collected through centrifugation and
washed three times with PBS. After the ﬁnal wash, the supernatant was
discarded, and the pellet was dissolved in SDS lysis buffer and boiled in
ﬁvefold SDS loading dye for 5 min. The proteins were resolved through
10% SDS-PAGE and transferred to polyvinylidene ﬂuoride membranes.
Immunoprecipitated proteins were subsequently detected using anti-P2X7
and anti-CD44 antibodies, followed by incubation with the respective
secondary antibodies conjugated to horseradish peroxidase. The bands
were revealed using the SuperSignal West Pico Chemiluminescent
Substrate.63
Molecular dynamics and free-energy calculation
Model building. The structure of the P2X7 receptor was constructed
through homology modeling using the software program Modeler6v2,64
using the P2X4 receptor as template, Protein Data Bank entry code 3H9V.
The model was energy-minimized (100 cycles of steepest descent) using
GROMACS-4.5.1,65,66 and submitted to 50 ns dynamics simulation.
Heparin and ATP topology construction. The heparin coordinates and
topologies were generated as previously described.67,68 Brieﬂy, saccharides
composing fragments were constructed using MOLDEN software,69 and
the structures were submitted to the PRODRG server.70 Thereafter, using
minimized output conformations, a series of MD simulations were
performed for 20 ps at 10 K, with an integration step of 0.5 fs, to further
reinforce the search for minimum-energy states. Relaxed structures were
used to perform docking experiments. ATP topology is part of the
GROMOS96 43a1 force ﬁeld.71
Docking. The location of ATP was determined through superimposition
with 3H9V using the software program Modeler6v2. The docking of
heparin onto the P2X7 receptor models (P2X7 alone and P2X7 containing
ATP) was performed using the software program Autodock 4.2.72 The
Löwdin atomic charges for sulfated saccharides were used,73,74 and all
torsion angles were considered to be ﬂexible. The grid maps were
calculated using AutoGrid, and the grid dimensions were set to 160
Å×150 Å×80 Å, with 0.3 Å spacing between the grid points. The region
between two monomers was also considered during the docking runs. For
each simulation, 500 runs of genetic algorithm were performed using a
population of 1000 individuals, a maximum number of 2.5 × 108 energy
evaluations, a 0.02 mutation rate, a 0.80 crossover rate and an elitism value
of 1. The results were clustered according to the 0.4-Å RMSD criteria and
the Autodock score.
Molecular dynamics simulations. Molecular dynamics simulation was
performed using GROMACS-4.5.1 with the GROMOS96 43a1 force ﬁeld.
The P2X7 trimer alone, ATP-bound or ATP/heparin-bound was solvated in
rectangular boxes using periodic boundary conditions and the SPC water
model.75 Counter ions (Na+ and Cl−) were added to neutralize the system,
whenever needed. The employed MD protocol was based on previous
studies.67 The Lincs method76 was applied to constrain covalent bond
lengths, allowing an integration step of 2 fs after an initial energy
minimization using the Steepest Descents algorithm. Electrostatic inter-
actions were calculated using the Particle Mesh Ewald method.77
Temperature and pressure were maintained through the coupling protein,
heparin, ATP, ions and solvent to external temperature and pressure baths
with coupling constants of τ=0.1 and 0.5 ps, respectively. The dielectric
constant was treated as ε=1. The systems were slowly heated from 50 to
310 K, in steps of 5 ps, each increasing the reference temperature by 50 K.
After heating, all simulations were further extended to 50 ns under a
constant temperature of 310 K. The hydrogen bonds were deﬁned when
the donor–acceptor heavy atom distance was 0.35 nm and the acceptor
atom–donor hydrogen angle was 30 degrees. Molecular dynamics
simulations were performed at the Ohio Supercomputer Center Oakley
Cluster, using a 16-processors system of 49 052 atoms at a rate of ~ 2.1 μs/
atom/timestep. Trajectories were acquired every 10 ps and were visualized
using VMD v1.9.178 and Pymol.79
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MM-PBSA binding free-energy calculation. Binding free-energy (DGbind)
calculations were performed using g_mmpbsa package.80 The trajectories
were compressed every 100th frame, and all three heparin-bound
monomers were analyzed. All 2D data were plotted using Grace 5.1
software (Free Software Foundation, Boston, MA, USA).
Statistical analysis
All data for each assay represent two independent experiments run at least
in triplicate (N=6), and are expressed as the mean± S.E.M. Statistical
signiﬁcance among the groups was assessed using one-way analysis of
variance ANOVA, followed by Tukey’s multiple comparison test. Student’s
t-test was also used to analyze the data when pertinent. Differences were
considered to be signiﬁcant when the P-values were o0.05 (Po0.05).
All statistical analyses were performed using GraphPad Prism software
(GraphPad, La Jolla, CA, USA).
ABBREVIATIONS
αβ-MeATP, α,β-methyleneadenosine 5′-triphosphate; βγ-MeATP, β,γ-
methyleneadenosine 5′-triphosphate; 2-MeSATP, 2-(methylthio)adenosine
5′-triphosphate; 7-AAD, 7-amino-actinomycin D; BzATP, 2′(3′)-O-(4-ben-
zoylbenzoyl)adenosine 5′-triphosphate; CHO, Cell line derived from the
ovary of the Chinese hamster; DAPI, 4ʹ-6-diamidino-2-phenylindole;
DMSO, dimethyl sulfoxide; ERM, Ezrin/Radixin/Moesin family; FBS, fetal
bovine serum; GAG, glycosaminoglycans; MTT, 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide; NMA, normal mode analysis; OxATP,
adenosine 5′-triphosphate periodate oxidized; P2X, ATP-gated cation
channel receptors family; P2X7, purinergic receptor P2X, ligand-gated ion
channel 7; P2Y, G-protein-coupled receptors family; P388D1, macrophage-
like cell line derived from murine; PI, propidium iodide; RMSD, root mean
square deviation; sCD44, soluble CD44 ectodomain; TGF-β, transforming
growth factor-beta.
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